For all participants, including those who were biologic naive, significantly greater proportions achieved ACR50 at week 24 compared with placebo, although the improvement failed to reach significance for ACR70 (Table 1 ).
← all excerpts
The Role of Biological and Small Molecule Therapy in the Management of Psoriatic Arthritis
1
—
—